Kohli M - Search Results

1

miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.

Wang Y, Lieberman R, Pan J, Zhang Q, Du M, Zhang P, Nevalainen M, Kohli M, Shenoy NK, Meng H, You M, Wang L. Wang Y, et al. Among authors: kohli m. Mol Cancer. 2016 Nov 10;15(1):70. doi: 10.1186/s12943-016-0556-9. Mol Cancer. 2016. PMID: 27832783 Free PMC article.

2

Thrombin expression in prostate: a novel finding.

Kohli M, Williams K, Yao JL, Dennis RA, Huang J, Reeder J, Ricke WA. Kohli M, et al. Cancer Invest. 2011 Jan;29(1):62-7. doi: 10.3109/07357907.2010.535057. Cancer Invest. 2011. PMID: 21166500 Free PMC article.

3

Characterization of human plasma-derived exosomal RNAs by deep sequencing.

Huang X, Yuan T, Tschannen M, Sun Z, Jacob H, Du M, Liang M, Dittmar RL, Liu Y, Liang M, Kohli M, Thibodeau SN, Boardman L, Wang L. Huang X, et al. Among authors: kohli m. BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319. BMC Genomics. 2013. PMID: 23663360 Free PMC article.

4

eRNA: a graphic user interface-based tool optimized for large data analysis from high-throughput RNA sequencing.

Yuan T, Huang X, Dittmar RL, Du M, Kohli M, Boardman L, Thibodeau SN, Wang L. Yuan T, et al. Among authors: kohli m. BMC Genomics. 2014 Mar 5;15:176. doi: 10.1186/1471-2164-15-176. BMC Genomics. 2014. PMID: 24593312 Free PMC article.

5

Preclinical evaluation of the supercritical extract of azadirachta indica (neem) leaves in vitro and in vivo on inhibition of prostate cancer tumor growth.

Wu Q, Kohli M, Bergen HR 3rd, Cheville JC, Karnes RJ, Cao H, Young CY, Tindall DJ, McNiven MA, Donkena KV. Wu Q, et al. Among authors: kohli m. Mol Cancer Ther. 2014 May;13(5):1067-77. doi: 10.1158/1535-7163.MCT-13-0699. Epub 2014 Mar 27. Mol Cancer Ther. 2014. PMID: 24674886 Free PMC article.

6

Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer.

Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar R, Wang D, See W, Costello BA, Quevedo F, Tan W, Nandy D, Bevan GH, Longenbach S, Sun Z, Lu Y, Wang T, Thibodeau SN, Boardman L, Kohli M, Wang L. Huang X, et al. Among authors: kohli m. Eur Urol. 2015 Jan;67(1):33-41. doi: 10.1016/j.eururo.2014.07.035. Epub 2014 Aug 14. Eur Urol. 2015. PMID: 25129854 Free PMC article.

7

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer.

Xia S, Kohli M, Du M, Dittmar RL, Lee A, Nandy D, Yuan T, Guo Y, Wang Y, Tschannen MR, Worthey E, Jacob H, See W, Kilari D, Wang X, Hovey RL, Huang CC, Wang L. Xia S, et al. Among authors: kohli m. Oncotarget. 2015 Jun 30;6(18):16411-21. doi: 10.18632/oncotarget.3845. Oncotarget. 2015. PMID: 25915538 Free PMC article.

8

Plasma extracellular RNA profiles in healthy and cancer patients.

Yuan T, Huang X, Woodcock M, Du M, Dittmar R, Wang Y, Tsai S, Kohli M, Boardman L, Patel T, Wang L. Yuan T, et al. Among authors: kohli m. Sci Rep. 2016 Jan 20;6:19413. doi: 10.1038/srep19413. Sci Rep. 2016. PMID: 26786760 Free PMC article.

9

Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.

Xia Y, Huang CC, Dittmar R, Du M, Wang Y, Liu H, Shenoy N, Wang L, Kohli M. Xia Y, et al. Among authors: kohli m. Oncotarget. 2016 Jun 14;7(24):35818-35831. doi: 10.18632/oncotarget.9027. Oncotarget. 2016. PMID: 27127882 Free PMC article.

10

Alterations of androgen receptor-regulated enhancer RNAs (eRNAs) contribute to enzalutamide resistance in castration-resistant prostate cancer.

Zhao J, Zhao Y, Wang L, Zhang J, Karnes RJ, Kohli M, Wang G, Huang H. Zhao J, et al. Among authors: kohli m. Oncotarget. 2016 Jun 21;7(25):38551-38565. doi: 10.18632/oncotarget.9535. Oncotarget. 2016. PMID: 27221037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

552 results

Search Page